Zinc is a potent and specific inhibitor of IFN-λ3 signalling
暂无分享,去创建一个
Kristina M. Cook | D. Booth | G. Ahlenstiel | P. Hogg | J. George | A. Cunningham | Chantelle L. Ahlenstiel | M. Douglas | V. Suppiah | S. Read | K. O’Connor | S. Obeid | Kate S. O’Connor
[1] Kristina M. Cook,et al. A substrate-driven allosteric switch that enhances PDI catalytic activity , 2016, Nature Communications.
[2] R. Diefenbach,et al. Abalone Hemocyanin Blocks the Entry of Herpes Simplex Virus 1 into Cells: a Potential New Antiviral Strategy , 2015, Antimicrobial Agents and Chemotherapy.
[3] Charles M. Rice,et al. Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.
[4] V. Wong,et al. Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease , 2015, Nature Communications.
[5] M. Diamond,et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection , 2015, Science.
[6] Maxim N. Artyomov,et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity , 2015, Science.
[7] M. Castro,et al. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. , 2014, The Journal of allergy and clinical immunology.
[8] M. Battegay,et al. IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza , 2014, PLoS pathogens.
[9] J. George,et al. Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production. , 2014, The Journal of general virology.
[10] Siyuan Ding,et al. Peroxisomal MAVS activates IRF1-mediated IFN-λ production , 2014, Nature Immunology.
[11] Steven H Kleinstein,et al. Dynamic expression profiling of type I and type III interferon‐stimulated hepatocytes reveals a stable hierarchy of gene expression , 2014, Hepatology.
[12] E. Galmozzi,et al. Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[13] C. Rice,et al. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. , 2014, Cell host & microbe.
[14] D. Booth,et al. Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent , 2014, Genes and Immunity.
[15] A. Iwasaki,et al. Epigenetic Reprogramming of the Type III Interferon Response Potentiates Antiviral Activity and Suppresses Tumor Growth , 2014, PLoS biology.
[16] S. Polyak,et al. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. , 2013, Journal of hepatology.
[17] L. Rink,et al. Differential Regulation of TLR-Dependent MyD88 and TRIF Signaling Pathways by Free Zinc Ions , 2013, The Journal of Immunology.
[18] Daniel W. A. Buchan,et al. Scalable web services for the PSIPRED Protein Analysis Workbench , 2013, Nucleic Acids Res..
[19] Z. Lee,et al. The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. , 2013, Autoimmunity reviews.
[20] D. Nebert,et al. ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB. , 2013, Cell reports.
[21] Qingrui Yang,et al. Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients , 2013, Autoimmunity.
[22] Barbara Rehermann,et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.
[23] A. Folgori,et al. IL‐29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection , 2012, Hepatology.
[24] Chunyu Liu,et al. Two Gene Co-expression Modules Differentiate Psychotics and Controls , 2012, Molecular Psychiatry.
[25] V. Adam,et al. Mammalian metallothioneins: properties and functions. , 2012, Metallomics : integrated biometal science.
[26] J. Niu,et al. IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels in Chinese Population , 2012, PloS one.
[27] J. Benito,et al. Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV. , 2012, Journal of Antimicrobial Chemotherapy.
[28] Qisheng Li,et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. , 2012, Gastroenterology.
[29] A. Hausrath,et al. Zinc enhances adiponectin oligomerization to octadecamers but decreases the rate of disulfide bond formation , 2012, BioMetals.
[30] M. Nakanishi,et al. Genetic Variation of the IL-28B Promoter Affecting Gene Expression , 2011, PloS one.
[31] E. Lourenço,et al. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity , 2011, Arthritis research & therapy.
[32] Haiyan Liu,et al. Structure-based de novo prediction of zinc-binding sites in proteins of unknown function , 2011, Bioinform..
[33] Julia E. Vogt,et al. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. , 2011, Gastroenterology.
[34] Jacques Fellay,et al. IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C , 2010, Hepatology.
[35] A. Wlodawer,et al. Crystal structure of the complex of human interferon-lambda1 with its high affinity receptor interferon-lambdaR1. , 2010 .
[36] A. Wlodawer,et al. Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1 , 2010, Journal of Molecular Biology.
[37] S. Smirnov,et al. Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo , 2010, Journal of Virology.
[38] Leiliang Zhang,et al. Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. , 2010, Gastroenterology.
[39] A. C. Looman,et al. Despite IFN-λ receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines , 2009, Genes and Immunity.
[40] A. Prasad,et al. Zinc: role in immunity, oxidative stress and chronic inflammation , 2009, Current opinion in clinical nutrition and metabolic care.
[41] David B. Goldstein,et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.
[42] Thomas Berg,et al. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.
[43] A. Koike,et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C , 2009, Nature Genetics.
[44] Jacques Fellay,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.
[45] S. Paludan,et al. Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family* , 2009, The Journal of Biological Chemistry.
[46] Carlos Prieto,et al. Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles , 2008, PloS one.
[47] J. Ceuppens,et al. Type III IFN‐λ mRNA expression in sputum of adult and school‐aged asthmatics , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[48] Edward J Oakeley,et al. Interferon signaling and treatment outcome in chronic hepatitis C , 2008, Proceedings of the National Academy of Sciences.
[49] A. Prasad,et al. Zinc in Human Health: Effect of Zinc on Immune Cells , 2008, Molecular medicine.
[50] T. Michiels,et al. IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo , 2008, PLoS pathogens.
[51] Jessica C. Ebert,et al. Robust recognition of zinc binding sites in proteins , 2007, Protein science : a publication of the Protein Society.
[52] V. Sobolev,et al. Prediction of transition metal‐binding sites from apo protein structures , 2007, Proteins.
[53] A. Nielsen,et al. Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases , 2007, Journal of Virology.
[54] T. Satoh,et al. Interferonbeta-induced changes in metallothionein expression and subcellular distribution of zinc in HepG2 cells. , 2006, Cytokine.
[55] Sangsoo Kim,et al. Gene expression Differential coexpression analysis using microarray data and its application to human cancer , 2005 .
[56] R. Ueda,et al. Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E , 2005, Journal of Virology.
[57] W. Achanzar,et al. Interferon alpha induction of metallothionein in rat liver is not linked to interleukin-1, interleukin-6, or tumor necrosis factor alpha. , 2005, Experimental and molecular pathology.
[58] R. Bartenschlager,et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.
[59] M. Hällbrink,et al. Metallic Zinc Reduction of Disulfide Bonds between Cysteine Residues in Peptides and Proteins , 2005, International Journal of Peptide Research and Therapeutics.
[60] T. Ganz,et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. T. Saari,et al. Abrogation of Nuclear Factor-κB Activation Is Involved in Zinc Inhibition of Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production and Liver Injury , 2004 .
[62] Bo Zhang,et al. Activity of Metal-Responsive Transcription Factor 1 by Toxic Heavy Metals and H2O2 In Vitro Is Modulated by Metallothionein , 2003, Molecular and Cellular Biology.
[63] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[64] A. Prasad. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. , 2000, The Journal of infectious diseases.
[65] U. Jakob,et al. Chaperone Activity with a Redox Switch , 1999, Cell.
[66] L. Rink,et al. Zinc supplementation reconstitutes the production of interferon-alpha by leukocytes from elderly persons. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[67] M. Mori,et al. The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients , 1997, Biological Trace Element Research.
[68] A. Hruza,et al. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. , 1996, Structure.
[69] Luchuan Liang,et al. Oxidative Stress Activates Metal-responsive Transcription Factor-1 Binding Activity , 1996, The Journal of Biological Chemistry.
[70] T. Yoshida,et al. Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status. , 1996, The Tohoku journal of experimental medicine.
[71] J. Berg,et al. The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc , 1996, Science.
[72] H. Hojo,et al. Differential induction of metallothionein synthesis by interleukin-6 and tumor necrosis factor-alpha in rat tissues. , 1994, International journal of immunopharmacology.
[73] R. Cousins,et al. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Cousins,et al. Tissue‐specific regulation of zinc metabolism and metallothionein genes by interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] M. Rousset,et al. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. , 1986, Biochimie.
[76] R. Pekarek,et al. Effect of Acute Infection and Endotoxemia on Zinc Absorption in the Rat , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[77] T. Michiels,et al. IFN-lambda ( IFN-lambda ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo , 2018 .
[78] G. Engelhardt,et al. The biochemical effects of extracellular Zn(2+) and other metal ions are severely affected by their speciation in cell culture media. , 2015, Metallomics : integrated biometal science.
[79] L. Rink,et al. Zinc signals and immune function , 2014, BioFactors.
[80] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[81] Antonio Rosato,et al. Counting the zinc-proteins encoded in the human genome. , 2006, Journal of proteome research.
[82] C. McClain,et al. Abrogation of nuclear factor-kappaB activation is involved in zinc inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha production and liver injury. , 2004, The American journal of pathology.
[83] Koichi Suzuki,et al. Properties and Functions , 1973 .